Clinical trial
A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients
NCT00401362 · Bausch Health Americas, Inc., Industry · Completed
Key facts
| NCT number | NCT00401362 |
|---|---|
| Title | A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients |
| Official title | A Double-Blind Placebo-Controlled Study of Methylnaltrexone (MNTX) for the Relief of Constipation Due to Chronic Opioid Therapy in Patients With Advanced Medical Illness |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Advanced Illness Patients With Opioid Induced Constipation |
| Intervention type | Drug |
| Interventions | SC Methylnaltrexone, SC Placebo |
| Enrollment | 154 |
| Start date | Feb 1, 2003 |
| Primary completion | Feb 1, 2005 |
| Completion | Feb 1, 2005 |
| First posted | Nov 20, 2006 |
| Last update posted | Nov 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: